The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Orangina Contract Win

12 Sep 2006 07:00

Embargoed: 0700hrs BST, 12 September 2006 Orangina Initiates Group-wide Implementation of Sopheon's Accolade Solution Leading European Soft Drink Producer Deploys Software System to Facilitate Better, More Profitable Innovation MINNEAPOLIS and LONDON ¡â€š¾ Sept. 12, 2006 ¡â€š¾ Sopheon, the international softwareand services company, announced today that Orangina Group, one of the largestsoft drink producers in Europe, is deploying Sopheon's Accolade product lifecycle management system to strengthen governance of the company's innovationprocess and increase the business returns from new products. The group-wideimplementation will encompass head-office sites and research-and-development (R&D) facilities in France, Spain, Belgium and the Netherlands.Stagnito's 2006 annual survey of R&D in the beverage industry found thatbeverage producers are continuing to focus on new product innovation as aprincipal way of increasing market share. The study determined that 47 percentof soft drink manufacturers can develop a product in less than six months.However, it also found that, overall, only half of the products emerging from R&D are commercialized, and one of every three soft drinks reaching themarketplace fails.Orangina Group is the number one soft drink producer in France, and the thirdlargest player in the European market. Its products are sold in 60 countries tomore than 500 million consumers. Sopheon's Accolade will allow Orangina tostrengthen the governance of its innovation process by providing decisionsupport and controls that enable more informed prioritization of productdevelopment projects. It will also ensure consistent alignment of resourceswith the most commercially promising product opportunities."We chose Sopheon's solution because we believe it can help us fast-track ourinnovation process," said Fergus Chapman, Group Marketing Capabilities Managerat Orangina. "Accolade's ease-of-use, flexibility, and powerful reportingcapabilities simplify the innovation process and, in doing so, theyoperationlize it. As a result, we can concentrate on the innovation itself, andreduce the time spent on processes. Accolade enables us to focus on the `what'rather than the `how' of innovation.""Orangina Group's business success reflects the company's long-standingstrategic emphasis on profitable innovation," said Mike Connolly, Europeandirector for Sopheon. "Accolade will provide them with the support they need todevelop the right priorities, strategies and activities to achieve maximumbusiness impact from their innovation efforts. Orangina Group's rationale foradopting our solution is an affirmation of Accolade's emergence as the processgovernance solution of choice among food and beverage companies that arelooking to innovation as a primary source of business value."Sopheon Accolade‚® is a registered trademark of Sopheon plc.Orangina‚® is a registered trademark of Orangina Group.All other trademarks and registered trademarks are the soleproperty of their respective owners.About OranginaOrangina Group is the number three player in the European soft drinks market.Its principal products are carbonated soft drinks, mineral waters and stilldrinks. Its main brands are Schweppes, Orangina, TriNa, Oasis and La Casera,which account for around 75% of sales. Other brands include Pampryl, Gini andVida. Products are sold across Continental Europe, with some sales in the UK,parts of North and West Africa and the Middle East.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product innovation. TheSopheon Accolade‚® product innovation process and portfolio management systemautomates gate- or phase-based product development processes and providesstrategic decision support that allows companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Ben Simons Hansard Group Tel : + 44 (0) 207 245 1100 Frank Jansen Citigate First Financial Tel : + 31 (0) 205 754 024ENDSOPHEON PLC
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.